Abstract
The design of selective COX-2 inhibitors is a new approach to obtain potent, anti-inflammatory drugs but with less side effects. Several families of such inhibitors were reported in literature. In this review, the drug design processes used to understand their binding mode and the origin of selectivity of these compounds are described.
Keywords: cox-2 inhibitor, selectivity, molecular modelling, x-ray, drug design, cox binding site, molecular features
Mini-Reviews in Medicinal Chemistry
Title: Structural Approach for COX-2 Inhibition
Volume: 4 Issue: 6
Author(s): C. Michaux and C. Charlier
Affiliation:
Keywords: cox-2 inhibitor, selectivity, molecular modelling, x-ray, drug design, cox binding site, molecular features
Abstract: The design of selective COX-2 inhibitors is a new approach to obtain potent, anti-inflammatory drugs but with less side effects. Several families of such inhibitors were reported in literature. In this review, the drug design processes used to understand their binding mode and the origin of selectivity of these compounds are described.
Export Options
About this article
Cite this article as:
Michaux C. and Charlier C., Structural Approach for COX-2 Inhibition, Mini-Reviews in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1389557043403756
DOI https://dx.doi.org/10.2174/1389557043403756 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Prophylaxis of Venous Thromboembolism in Major Orthopedic Surgery: A Practical Approach
Cardiovascular & Hematological Agents in Medicinal Chemistry Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia
Current Cancer Drug Targets Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Effects Of A Selective Histamine H<sub>4</sub>R Antagonist On Inflammation In A Model Of Carrageenan-Induced Pleurisy In The Rat
Current Pharmaceutical Design The Cellular Effects of Carbon Monoxide in the Airway
Current Molecular Medicine New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design C1 Inhibitor Administration Reduces Local Inflammation and Capillary Leakage, Without Affecting Long-term Wound Healing Parameters, in a Pig Burn Wound Model
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cryopreservation of Ovarian Tissue: State of the Art in 2007
Current Women`s Health Reviews Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Current Alzheimer Research Ferritin and Percent Transferrin Saturation Levels Predict Type 2 Diabetes Risk and Cardiovascular Disease Outcomes
Current Diabetes Reviews Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Pathophysiology of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Cardiac Morbidity in an HIV-1 Lipodystrophy Patient Cohort Expressing the TNF-α-238 G/A Single Nucleotide Gene Polymorphism
Current HIV Research Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Preface
Current Tissue Engineering (Discontinued) Quetiapine Fumarate Loaded Mucoadhesive Nanoemulsion: Formulation, Optimization & Brain Delivery via Intranasal Administration
Drug Delivery Letters Biomarkers of Atrial Fibrillation in Metabolic Syndrome
Current Medicinal Chemistry